Embecta EMBC
NASDAQ EMBC
$5.59 +0.29 (+5.47%)
At close: Sep 22, 2026 · 4:00 PM EDT

Embecta (EMBC) Cash from Investing Activities (2020 - 2026)

Embecta's (EMBC) quarterly Cash from Investing Activities came in at -$129.5 million in Q2 2026, down 32275.0% year-over-year from N/an in Q2 2025, and down 25800.0% quarter-over-quarter from -$500000.0 in Q1 2026.

Analysis

Embecta (EMBC) Cash from Investing Activities (2020 - 2026) Analysis & Trends

Embecta has disclosed Cash from Investing Activities across 7 years of filings, most recently posting -$129.5 million for Q2 2026.

  • In Q2 2026, Cash from Investing Activities fell 32275.0% year-over-year to -$129.5 million; the TTM figure through Jun 2026 stood at -$127.8 million (down 6290.0% YoY), while the FY2025 annual figure was -$9.3 million, up 41.14% from the prior year.
  • Cash from Investing Activities came in at -$129.5 million for Q2 2026 at Embecta, down from -$500000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $9.5 million in Q4 2025 to a low of -$129.5 million in Q2 2026.
  • Average Cash from Investing Activities over 5 years is -$11.3 million, with a median of -$5.3 million recorded in 2022.
  • Year-over-year, Cash from Investing Activities surged 733.33% in 2025 and sank 32275.0% in 2026.
  • Over 5 years, Cash from Investing Activities stood at -$4.7 million in 2022, then surged by 42.55% to -$2.7 million in 2023, then soared by 44.44% to -$1.5 million in 2024, then surged by 733.33% to $9.5 million in 2025, then slumped by 1463.16% to -$129.5 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$129.5 million in Q2 2026, -$500000.0 in Q1 2026, and $9.5 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Abbott Laboratories 178.18 Bn 173.23 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 142.14 Bn 137.06 Bn 1.96 Bn -26.60 Mn
3 Medtronic 117.43 Bn 109.23 Bn 6.34 Bn -1.62 Bn
4 Stryker 105.15 Bn 101.68 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 63.37 Bn 63.08 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 50.93 Bn 46.79 Bn 1.35 Bn -193.20 Mn
7 Dexcom 33.65 Bn 31.71 Bn 830.00 Mn 329.80 Mn
8 Resmed 32.27 Bn 30.80 Bn 861.22 Mn -383.65 Mn
9 Alcon 31.62 Bn 30.17 Bn 1.68 Bn -222.00 Mn
10 Embecta 300.30 Mn 82.10 Mn 153.30 Mn -129.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -129.50 Mn
Mar 31, 2026 -500,000.00
Dec 31, 2025 9.50 Mn
Sep 30, 2025 -7.30 Mn
Jun 30, 2025 -400,000.00
Mar 31, 2025 -100,000.00
Dec 31, 2024 -1.50 Mn
Jun 30, 2024 -9.70 Mn
Mar 31, 2024 -3.40 Mn
Dec 31, 2023 -2.70 Mn
Sep 30, 2023 -9.20 Mn
Jun 30, 2023 -6.80 Mn
Mar 31, 2023 -5.80 Mn
Dec 31, 2022 -4.70 Mn
Sep 30, 2022 -8.60 Mn
Jun 30, 2022 -5.30 Mn
Mar 31, 2022 -5.80 Mn
Dec 31, 2021 -4.30 Mn
Sep 30, 2021 -13.30 Mn
Jun 30, 2021 -7.70 Mn
API Access

Embecta Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=EMBC&period=max&api_key=YOUR_API_KEY